These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
585 related items for PubMed ID: 16776855
1. Phytoestrogens and cardiovascular disease. Cassidy A, Hooper L. J Br Menopause Soc; 2006 Jun; 12(2):49-56. PubMed ID: 16776855 [Abstract] [Full Text] [Related]
2. Soy isoflavones affect platelet thromboxane A2 receptor density but not plasma lipids in menopausal women. Garrido A, De la Maza MP, Hirsch S, Valladares L. Maturitas; 2006 Jun 20; 54(3):270-6. PubMed ID: 16414215 [Abstract] [Full Text] [Related]
4. Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Sacks FM, Lichtenstein A, Van Horn L, Harris W, Kris-Etherton P, Winston M, American Heart Association Nutrition Committee. Circulation; 2006 Feb 21; 113(7):1034-44. PubMed ID: 16418439 [Abstract] [Full Text] [Related]
5. [Phytoestrogens]. Zittermann A. Zentralbl Gynakol; 2003 Jun 21; 125(6):195-201. PubMed ID: 14556117 [Abstract] [Full Text] [Related]
6. Soy consumption and phytoestrogens: effect on serum prostate specific antigen when blood lipids and oxidized low-density lipoprotein are reduced in hyperlipidemic men. Jenkins DJ, Kendall CW, D'Costa MA, Jackson CJ, Vidgen E, Singer W, Silverman JA, Koumbridis G, Honey J, Rao AV, Fleshner N, Klotz L. J Urol; 2003 Feb 21; 169(2):507-11. PubMed ID: 12544298 [Abstract] [Full Text] [Related]
7. Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women. Teede HJ, Dalais FS, Kotsopoulos D, Liang YL, Davis S, McGrath BP. J Clin Endocrinol Metab; 2001 Jul 21; 86(7):3053-60. PubMed ID: 11443167 [Abstract] [Full Text] [Related]
8. Soy isoflavone supplementation and fasting serum glucose and lipid profile among postmenopausal Chinese women: a double-blind, randomized, placebo-controlled trial. Ho SC, Chen YM, Ho SS, Woo JL. Menopause; 2007 Jul 21; 14(5):905-12. PubMed ID: 17413839 [Abstract] [Full Text] [Related]
12. A review of the clinical effects of phytoestrogens. Knight DC, Eden JA. Obstet Gynecol; 1996 May 21; 87(5 Pt 2):897-904. PubMed ID: 8677131 [Abstract] [Full Text] [Related]
13. Soy isoflavones: are they useful in menopause? Vincent A, Fitzpatrick LA. Mayo Clin Proc; 2000 Nov 21; 75(11):1174-84. PubMed ID: 11075748 [Abstract] [Full Text] [Related]
15. Lack of effects of isoflavones on the lipid profile of Brazilian postmenopausal women. Rios DR, Rodrigues ET, Cardoso AP, Montes MB, Franceschini SA, Toloi MR. Nutrition; 2008 Nov 21; 24(11-12):1153-8. PubMed ID: 18842392 [Abstract] [Full Text] [Related]
16. Pharmacological activities of Genistein, an isoflavone from soy (Glycine max): part II--anti-cholesterol activity, effects on osteoporosis & menopausal symptoms. Suthar AC, Banavalikar MM, Biyani MK. Indian J Exp Biol; 2001 Jun 21; 39(6):520-5. PubMed ID: 12562012 [Abstract] [Full Text] [Related]
17. [Consumption of soy and phytoestrogens--is there a place for dietary guidelines?]. Shamir R, Rozen G. Harefuah; 2002 Jan 21; 141(1):44-5, 126. PubMed ID: 11851107 [Abstract] [Full Text] [Related]
19. Effect of isoflavones on lipids and bone turnover markers in menopausal women. Schult TM, Ensrud KE, Blackwell T, Ettinger B, Wallace R, Tice JA. Maturitas; 2004 Jul 15; 48(3):209-18. PubMed ID: 15207886 [Abstract] [Full Text] [Related]
20. Effects of soy isoflavones on menopausal neurovegetative symptoms. Colacurci N, Zarcone R, Borrelli A, De Franciscis P, Fortunato N, Cirillo M, Fornaro F. Minerva Ginecol; 2004 Oct 15; 56(5):407-12. PubMed ID: 15531858 [Abstract] [Full Text] [Related] Page: [Next] [New Search]